Internal Medicine, Hematology & Oncology · St George, UT
NPI
1700946423
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2019 E Riverside Dr Ste A200
St George, UT, 84790
Phone (435) 628-9298
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.4M
286,896 services
Medicare patients, 2024
1,189
Average age 76
Drug cost, 2024
$8.4M
1,592 prescriptions
Company payments, 2025
$5,316
From 38 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph D Te was code J1439 (injection, ferric carboxymaltose, 1 mg), 37,500 times for 26 patients. In total Joseph D Te billed 286,896 services in 196 codes, and Medicare paid $4.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 37,500 | 26 | $0.87 | $33K |
| J0897 Injection, denosumab, 1 mg | Office | 23,460 | 158 | $20.37 | $478K |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 7,910 | 12 | $5.86 | $46K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 4,650 | 12 | $0.11 | $534 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,861 | 41 | $0.09 | $347 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 3,595 | 11 | $6.22 | $22K |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 3,168 | 11 | $19.98 | $63K |
| 85025 Blood Count | Office | 2,489 | 748 | $7.60 | $19K |
| 36415 Venipuncture Blood Collection | Office | 2,022 | 720 | $8.64 | $17K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,920 | 35 | $0.71 | $1,358 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,823 | 898 | $11.38 | $21K |
| 99214 Office E&M - Established | Office | 1,655 | 589 | $90.00 | $149K |
| 80053 Clinical Chemistry | Office | 1,370 | 696 | $10.33 | $14K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,160 | 16 | $0.07 | $86.09 |
| J3480 Injection, potassium chloride, per 2 meq | Office | 921 | 14 | $0.09 | $80.86 |
By year: 2022 $4.6M for 327,439 services; 2023 $4.5M for 271,092 services; 2024 $4.4M for 286,896 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,489 | 748 | $7.60 | $19K |
| 36415 Venipuncture Blood Collection | 2,022 | 720 | $8.64 | $17K |
| 80053 Clinical Chemistry | 1,370 | 696 | $10.33 | $14K |
| 80047 Clinical Chemistry | 885 | 161 | $13.41 | $12K |
| 80076 Clinical Chemistry | 819 | 153 | $7.98 | $6,533 |
| 82784 Immunoassay | 638 | 126 | $9.11 | $5,814 |
| 83615 Clinical Chemistry | 359 | 210 | $5.91 | $2,121 |
| 84550 Clinical Chemistry | 324 | 138 | $4.43 | $1,435 |
| 82378 Clinical Chemistry | 290 | 108 | $18.58 | $5,388 |
| 82728 Clinical Chemistry | 241 | 172 | $13.23 | $3,188 |
Medicare prescription drug claims, 2024
In 2024, the drug Joseph D Te prescribed most often to Medicare patients was Abiraterone Acetate, with 183 prescriptions and refills. In total Joseph D Te wrote 1,592 Medicare prescriptions that cost $8.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Abiraterone Acetate Generic | 183 | 183 | 26 | $494K |
| Prednisone Generic | 148 | 157 | 41 | $1,032 |
| Imbruvica Ibrutinib | 123 | 123 | 11 | $2.0M |
| Calquence Acalabrutinib Maleate | 71 | 71 | Under 11 | $1.1M |
| Anastrozole Generic | 69 | 155 | 29 | $1,051 |
| Ondansetron Hcl Generic | 54 | 54 | 42 | $369 |
| Lenalidomide Generic | 44 | 44 | Under 11 | $628K |
| Prochlorperazine Maleate Generic | 43 | 43 | 33 | $795 |
| Allopurinol Generic | 42 | 75 | 18 | $197 |
| Revlimid Lenalidomide | 40 | 40 | Under 11 | $669K |
| Ondansetron Odt Ondansetron | 40 | 40 | 18 | $728 |
| Hydroxyurea Generic | 38 | 71 | 18 | $486 |
| Potassium Chloride Generic | 35 | 39 | 20 | $425 |
| Imatinib Mesylate Generic | 28 | 28 | Under 11 | $6,458 |
| Lorazepam Generic | 28 | 28 | 22 | $110 |
Brand drugs: 483 claims; generic drugs: 1,109 claims; opioid claims: 59.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph D Te $5,316 ($5,316 in general payments such as food, travel and fees) from 38 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,334.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 27 | $1,334 |
| AstraZeneca Pharmaceuticals LP AZN | 19 | $391 |
| Janssen Biotech, Inc. JNJ | 13 | $357 |
| Merck Sharp & Dohme LLC MRK | 14 | $354 |
| E.R. Squibb & Sons, L.L.C. BMY | 14 | $273 |
| Genentech USA, Inc. ROG.SW | 10 | $257 |
| Pfizer Inc. PFE | 19 | $231 |
| Incyte Corporation INCY | 9 | $187 |
| Abbvie Inc. ABBV | 9 | $183 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 7 | $166 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.